Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Gross Margin (2016 - 2025)

Angiodynamics (ANGO) has disclosed Gross Margin for 16 consecutive years, with 56.38% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 160.0% year-over-year to 56.38%, compared with a TTM value of 54.58% through Nov 2025, up 187.0%, and an annual FY2025 reading of 53.92%, up 301.0% over the prior year.
  • Gross Margin was 56.38% for Q4 2025 at Angiodynamics, up from 55.29% in the prior quarter.
  • Across five years, Gross Margin topped out at 56.38% in Q4 2025 and bottomed at 47.7% in Q1 2024.
  • Average Gross Margin over 5 years is 52.79%, with a median of 52.72% recorded in 2022.
  • The sharpest move saw Gross Margin crashed -362bps in 2021, then surged 627bps in 2025.
  • Year by year, Gross Margin stood at 51.81% in 2021, then increased by 2bps to 52.77% in 2022, then fell by -4bps to 50.92% in 2023, then increased by 8bps to 54.78% in 2024, then increased by 3bps to 56.38% in 2025.
  • Business Quant data shows Gross Margin for ANGO at 56.38% in Q4 2025, 55.29% in Q3 2025, and 52.67% in Q2 2025.